PURPOSE: The purpose of OncoMX1 knowledgebase development was to integrate cancer biomarker and relevant data types into a meta-portal, enabling the research of cancer biomarkers side by side with other pertinent multidimensional data types. METHODS: Cancer mutation, cancer differential expression, cancer expression specificity, healthy gene expression from human and mouse, literature mining for cancer mutation and cancer expression, and biomarker data were integrated, unified by relevant biomedical ontologies, and subjected to rule-based automated quality control before ingestion into the database. RESULTS: OncoMX provides integrated data encompassing more than 1,000 unique biomarker entries (939 from the Early Detection Research Network [EDRN] and 96 from the US Food and Drug Administration) mapped to 20,576 genes that have either mutation or differential expression in cancer. Sentences reporting mutation or differential expression in cancer were extracted from more than 40,000 publications, and healthy gene expression data with samples mapped to organs are available for both human genes and their mouse orthologs. CONCLUSION: OncoMX has prioritized user feedback as a means of guiding development priorities. By mapping to and integrating data from several cancer genomics resources, it is hoped that OncoMX will foster a dynamic engagement between bioinformaticians and cancer biomarker researchers. This engagement should culminate in a community resource that substantially improves the ability and efficiency of exploring cancer biomarker data and related multidimensional data.
PURPOSE: The purpose of OncoMX1 knowledgebase development was to integrate cancer biomarker and relevant data types into a meta-portal, enabling the research of cancer biomarkers side by side with other pertinent multidimensional data types. METHODS:Cancer mutation, cancer differential expression, cancer expression specificity, healthy gene expression from human and mouse, literature mining for cancer mutation and cancer expression, and biomarker data were integrated, unified by relevant biomedical ontologies, and subjected to rule-based automated quality control before ingestion into the database. RESULTS:OncoMX provides integrated data encompassing more than 1,000 unique biomarker entries (939 from the Early Detection Research Network [EDRN] and 96 from the US Food and Drug Administration) mapped to 20,576 genes that have either mutation or differential expression in cancer. Sentences reporting mutation or differential expression in cancer were extracted from more than 40,000 publications, and healthy gene expression data with samples mapped to organs are available for both human genes and their mouse orthologs. CONCLUSION:OncoMX has prioritized user feedback as a means of guiding development priorities. By mapping to and integrating data from several cancer genomics resources, it is hoped that OncoMX will foster a dynamic engagement between bioinformaticians and cancer biomarker researchers. This engagement should culminate in a community resource that substantially improves the ability and efficiency of exploring cancer biomarker data and related multidimensional data.
Authors: Jeremy L Warner; Dmitry Dymshyts; Christian G Reich; Michael J Gurley; Harry Hochheiser; Zachary H Moldwin; Rimma Belenkaya; Andrew E Williams; Peter C Yang Journal: J Biomed Inform Date: 2019-06-22 Impact factor: 6.317
Authors: Jun Li; Rehan Akbani; Wei Zhao; Yiling Lu; John N Weinstein; Gordon B Mills; Han Liang Journal: Cancer Res Date: 2017-11-01 Impact factor: 12.701
Authors: Christopher J Mungall; Carlo Torniai; Georgios V Gkoutos; Suzanna E Lewis; Melissa A Haendel Journal: Genome Biol Date: 2012-01-31 Impact factor: 13.583
Authors: Bethan Yates; Bryony Braschi; Kristian A Gray; Ruth L Seal; Susan Tweedie; Elspeth A Bruford Journal: Nucleic Acids Res Date: 2016-10-30 Impact factor: 16.971
Authors: Janisha A Patel; Dennis A Dean; Charles Hadley King; Nan Xiao; Soner Koc; Ekaterina Minina; Anton Golikov; Phillip Brooks; Robel Kahsay; Rahi Navelkar; Manisha Ray; Dave Roberson; Chris Armstrong; Raja Mazumder; Jonathon Keeney Journal: Database (Oxford) Date: 2021-03-30 Impact factor: 3.451
Authors: David S Wishart; Brendan Bartok; Eponine Oler; Kevin Y H Liang; Zachary Budinski; Mark Berjanskii; AnChi Guo; Xuan Cao; Michael Wilson Journal: Nucleic Acids Res Date: 2021-01-08 Impact factor: 16.971